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Abstract
Recombination, together with mutation, is the ultimate source of genetic variation in populations. 
We leverage the recent mixture of people of African and European ancestry in the Americas to 
build a genetic map measuring the probability of crossing-over at each position in the genome, 
based on about 2.1 million crossovers in 30,000 unrelated African Americans. At intervals of more 
than three megabases it is nearly identical to a map built in Europeans. At finer scales it differs 
significantly, and we identify about 2,500 recombination hotspots that are active in people of West 
African ancestry but nearly inactive in Europeans. The probability of a crossover at these hotspots 
is almost fully controlled by the alleles an individual carries at PRDM9 (P<10−245). We identify a 
17 base pair DNA sequence motif that is enriched in these hotspots, and is an excellent match to 
the predicted binding target of African-enriched alleles of PRDM9.
In humans and many other species, recombination is not evenly distributed across the 
genome, but instead occurs in “hotspots”: two kilobase (kb) segments where the crossover 
rate is far higher than in the flanking DNA sequence1,2,3. The highest resolution genetic map 
in contemporary humans to date, the “deCODE Map”, is based on about 500,000 crossovers 
identified in 15,000 Icelandic meioses4. However, a limitation of maps built in people of 
European descent4,5,6 is that they may not apply equally well in other populations, as 
suggested by comparisons of maps across ethnic groups4,7,8,9 and patterns of linkage 
disequilibrium (LD) breakdown which suggest that more of the genome may be 
recombinationally active in West Africans10. It is known that a major determinant of the 
positions of recombination hotspots is PRDM9, a meiosis-specific histone H3 
methyltransferase whose zinc finger (ZF) domain binds DNA sequence motifs11,12,13. In 
Europeans, PRDM9 ZF arrays are predominantly of two similar types, “A” and “B”, both of 
which bind the 13-bp motif CCNCCNTNNCCNC11. In contrast, 36% of West African 
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alleles are not of the A or B type9,13. Sperm typing of males who carry neither the A nor the 
B allele has shown no evidence of crossover activity at recombination hotspots associated 
with the 13-bp motif9.
To investigate differences in the crossover landscape across human populations, we built a 
genetic map in African Americans, who have an average of about 80% West African and 
20% European ancestry, leading to genomes comprised of multi-megabase stretches of 
either West African or European ancestry14. Computational approaches, including 
HAPMIX15, have been developed to infer the probability of 0, 1 or 2 European or African 
alleles at each locus in individuals genotyped at hundreds of thousands of single nucleotide 
polymorphisms (SNPs)15,16,17. Positions where the inferred number of European or African 
alleles changes reflect crossover events that have occurred since admixture began (on 
average six generations ago15). The change in the probability of European ancestry between 
adjacent SNPs can be interpreted as the probability of such a crossover between them. We 
inferred crossover events in 29,589 apparently unrelated African Americans who had been 
genotyped on SNP arrays in genetic association studies (Methods; Figure 1A). To minimize 
false-positive crossovers, we restricted to crossovers that HAPMIX inferred with probability 
of >95%, and that were flanked by a minimum of 2 centimorgan (cM) stretches where the 
ancestry was inferred to be unchanging (Note S1). This produced 2,113,293 highconfidence 
crossovers, with a typical switch point resolved within 70kb with probability 50% (Note S1).
To build a high resolution African American genetic map (AA Map), we leveraged the fact 
that most crossovers occur in hotspots shared across individuals1 (Methods). Intuitively, 
while any crossover can only be roughly localized, inter-SNP intervals that are inferred to 
have an appreciable probability of crossover in multiple individuals are likely to contain 
recombination hotspots, allowing much better localization (Figure S1). To implement this 
idea, we modeled the recombination rate for each inter-SNP interval as shared across 
individuals, and used a Markov Chain Monte Carlo (MCMC) to sample rates consistent with 
the data (Methods). This provides well-calibrated estimates of the crossing-over rate 
between all pairs of markers as well as estimates of rate uncertainty (Note S1 and Figure 
S2). We find that the interval size at which the average recombination rate is equal to the 
standard error is 6 kb, which is the same accuracy that would be expected from a map based 
on 500,000 crossovers whose boundaries were precisely resolved (Note S1). Despite this 
high resolution, there are also some limitations. First, the AA Map does not separately infer 
male and female recombination rates (it is a sex-averaged map) and requires normalization 
by the total map length (like LD maps3,18). Second, the map has less resolution and may 
miss a higher fraction of true crossovers at loci where it is more difficult to detect and 
resolve crossovers due to low SNP density or low differentiation between West Africans and 
Europeans. Third, the map may be biased where ancestry deviates from the average, for 
example at 8q24, where the 10% of the people in this study who have prostate cancer have 
an elevated proportion of African ancestry19. Fourth, the map assumes that all individuals 
are unrelated, whereas in fact there is likely some shared ancestry, resulting in multiple 
counting of some crossovers and an overestimate of map precision.
To assess the accuracy of the AA Map, we generated an independent African American 
pedigree map by analyzing 222 nuclear families that included 1,056 meioses in which we 
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could directly detect crossovers between parent and child (Methods; Figure 1A). 
Examination of the AA Map rate around directly detected crossovers confirms the high 
resolution: the rate around such crossovers shows at least as strong a peak as that observed 
in maps based on LD2,3,18 (Figure S3). We next computed correlation coefficients for both 
the AA Map and the deCODE Map4 to maps derived from the breakdown of LD in 
Europeans (CEU) and West Africans (YRI)18. At broad scales (>3 Mb) they are almost 
identical (ρ>0.97; Table 1) At fine scales, the AA Map is more accurate (Table 1 and Table 
S1), as reflected in a modest improvement in correlation to the CEU Map at a 3kb scale 
(ρAA,CEU(3kb) = 0.66 vs. ρdeCODE,CEU(3kb) = 0.58), and a major improvement for the YRI 
Map (ρAA,YRI(3kb) = 0.71 vs. ρdeCODE,YRI(3kb) = 0.53). The deCODE Map is more 
correlated to the CEU Map than to the YRI Map at scales <1 Mb, suggesting that this map, 
built in Icelanders, reflects more European recombination rates. The AA Map shows the 
opposite pattern, suggesting that it reflects more West African recombination patterns.
We compared the rate estimates for all four maps (AA, deCODE, CEU and YRI) over a 200 
kb region within the MHC locus where recombination rates in European males have been 
characterized through sperm typing1 (Figure 1B). The AA Map detects five of six known 
hotspots, and localizes them to within 1 kb (the sixth hotspot is weak, with a peak male rate 
below the genome average1). Strikingly, the two maps based on samples with African 
ancestry (AA and YRI) found a hotspot not present in either map based on samples of 
European ancestry (deCODE and CEU) (Figure 1C; Figure S4 gives a second example). We 
confirmed that such “African-enriched” hotspots also occur genome-wide, by examining 
2,375 loci with recombination rate peaks in the YRI Map (>5 cM/Mb) but not the CEU Map 
(<1 cM/Mb), and finding a rate rise in the independently generated AA Map, but not in the 
deCODE Map (Figure S5A). In the reciprocal experiment searching for European-specific 
hotspots, we find no such evidence for genuine ancestry specificity; at loci with 
recombination rate peaks in the CEU Map but not the YRI Map, there are weak peaks in 
both the deCODE and AA maps (Methods; Figure S5B). Thus, hotspots active in Europeans 
are consistently “shared” with YRI and African Americans, while populations with African 
ancestry harbor additional, non-shared hotspots we call “African-enriched”.
To understand the features of recombination in West Africans that differ from Europeans, 
we estimated the degree to which each African American person’s crossovers occur in 
“African-enriched” hotspots, compared with “Shared” hotpots, a phenotype we refer to as 
their “African-enrichment” (AE). We view each individual’s crossovers as sampled from a 
mixture of two genetic maps—an “S Map” of shared hotspots based on the deCODE Map, 
and an “AE Map” of African-enriched hotspots that is learned from comparing the deCODE 
and AA Maps—so that the proportion of crossovers assigned to the AE Map is a person’s 
AE phenotype (Note S4). We tested approximately 3 million SNPs (genotyped and imputed) 
for association with three phenotypes: AE, usage of LD-based hotspots known to be 
enriched for the 13-bp motif CCNCCNTNNCCNC20, and genome-wide crossover rate (in 
pedigrees) (Methods and Note S4). In crossovers detected in unrelated African Americans, 
the alleles a person carries are only sometimes descended from the ancestor in whom the 
crossover occurred, thus adding noise to the association signal (nevertheless there is useful 
signal given the large sample size; Note S4). In the Pedigree Map, association between 
alleles and AE can be tested directly because we have genotypes in the parents.
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The SNP showing the strongest association with AE is rs6889665 (P=1.5×10−246; Figure 
2A, Figure S6), which has a derived allele frequency of 29% in YRI and 2% in CEU, and is 
within 4 kb of the ZF array of PRDM94,9,11,12,13. This SNP is associated with AE in both 
the pedigree individuals and the unrelated individuals (Note S4), and is also the SNP most 
strongly associated with usage of LD-based hotspots (P=1.8×10−52) (Table S2). No locus 
outside PRDM9 is significant (P<0.01 after Bonferroni correction; Table S3). To better 
understand the association at rs6889665, we inferred the alleles in the PRDM9 ZF array 
carried by 139 individuals based on sequencing data from the 1000 Genomes Project21, 
using the reads to infer each individual’s PRDM9 alleles among 29 alleles whose full 
sequences were previously determined9 (Note S5). Grouping PRDM9 alleles based on how 
closely their binding target predictions match the 13-bp motif, following Berg et al.9, we 
find that the ancestral “T” variant at rs6889665 is strongly correlated to “8/8 matches” to the 
13-bp motif (including the “A” and “B” alleles ), while the derived “C” variant is almost 
perfectly correlated to a group of “5/8 match” alleles, all predicted to bind a common, 
different, 17-bp motif “CCgCNgtNNNCgtNNCC”9. This implies a common historical origin 
for alleles matching this 17-bp motif (Figure 2B; Figure S7; Note S5). We also 
experimentally measured the number of zinc fingers in PRDM9 in 354 individuals including 
166 African Americans from the pedigree study (Methods). This showed, again, that 
rs6889665 differentiates PRDM9 alleles into two different classes, with 96% of haplotypes 
carrying the ancestral allele having <14 zinc fingers, and 93% of haplotypes carrying the 
derived allele having ≥14 zinc fingers (Figure S7). After conditioning on rs6889665, there is 
no evidence that ZF length is associated with the AE phenotype. Several SNPs near the 
PRDM9 ZF array show a conditional association signal that is much weaker than rs6889665, 
but still significant (Figure 2C; Figure S6; Note S4), with the strongest at rs10043097 (P= 
8.3×10−14), upstream of the PRDM9 transcription start site. These SNPs may tag additional 
variation in PRDM9 ZF array, or potentially expression levels.
To directly identify candidate African-enriched hotspot motifs, we selected 2,454 loci with a 
high crossover rate in the AE Map and YRI Map (>2cM/Mb over 2kb), and no more than 
half this rate in the S Map and CEU Map (this set is more powerfully enriched for higher 
recombination in people of African ancestry than the 2,375 above, as it includes information 
from the contemporary maps). We compared these to a “control set” of 7,328 candidate 
hotspots more active in the European than the African derived maps (Methods; Note S6). To 
identify sequence motifs associated with the African-enriched hotspots3,22, we identified 
short motifs that occurred at increased frequency in the African-enriched hotspot set (Note 
S6). Testing all motifs of length 5–9 bases revealed a 9-mer “CCCCAGTGA” (OR=1.79, 
P=2.24×10−8, Bonferroni corrected P=0.004) which exhibited a kilobase-scale rate peak 
near occurrences of this motif in African derived maps, but in neither of the European 
derived maps (Figure S8). Further analysis revealed a strong influence of downstream 
flanking bases (Figure S9), and degeneracy, yielding a 17-bp consensus sequence 
“CCCCaGTGAGCGTtgCc” (Figure 3A; more strongly signaled bases are uppercase) with 
the same consensus obtained when we considered flanking sequence for only odd or even 
chromosomes, and whether we based the analysis on AE-S or YRI-CEU map comparisons 
(Note S6). The 500 best matches to this motif have a ~3-fold increase in average rate in the 
AA and YRI relative to the deCODE and CEU maps (Figure 3B, Figure S8). Hotspots 
Hinch et al. Page 4
Nature. Author manuscript; available in PMC 2012 February 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
associated with the motif occur in both unique and repetitive DNA (e.g. L1PA10/13 LINE 
elements; Figure S10) (Note S6). We also compared the 17-bp consensus to the binding 
motif predicted for “5/8 match” alleles, and found that they match almost precisely (Figure 
3A; 10 of 11 bases, P=8.1×10−6).
How much of the African-enriched recombination pattern can be explained by PRDM9? We 
estimated the fraction of variation in the AE phenotype explained by rs6889665 in our 
pedigree data after accounting for noise in the phenotype estimation (Note S4). Over 82% of 
map usage variability is explained by rs6889665 genotype alone. Given there are further 
influential PRDM9 variants (Figure 3C), this gene may thus explain almost all differences in 
local rate between the West African and European populations. We next examined rates 
around 82 narrowly defined (<10kb) crossover sites in 7 individuals homozygous for the 
derived allele at rs6889665. There is no evidence of hotspots at these loci in either the 
deCODE or CEU Maps (Figure 3C), in contrast to events in individuals carrying the 
ancestral allele at rs6889665 (Figure S11). Thus, crossover positions in individuals who are 
homozygous for the derived allele at rs6889665 are consistent with an entirely different 
recombination hotspot landscape, which would imply PRDM9 control of all hotspots9. 
Despite the strong correlation between maps at megabase scales, there is mounting evidence 
that PRDM9’s influence on crossing-over may not be limited to fine scales4,11: we observe a 
weakly significant association of rs6889665 with the total number of crossovers genome-
wide in pedigrees (P=0.04), corresponding to an average 1.3 crossovers more per meiosis 
per derived allele, exceeding the strongest previously known association23 at RNF212.
We have shown that PRDM9 alleles that bind a novel 17-bp motif and occur at greatly 
increased frequency in people of West African ancestry have led to a shift in the 
recombination landscape compared with people of non-African ancestry. The larger number 
of hotspots available to West Africans implies that at the population level, crossovers are 
more evenly distributed than in Europeans10, and thus the shorter extent of West African LD 
is not due to differences in demographic history alone (such as the lack of an out-of-Africa 
founder event)24. Our findings also have medical implications, as recombination errors 
leading to insertions or deletions are known to be associated with recombination 
hotspots9,22,25. Our results predict that the congenital abnormalities that have been 
associated with the recombination hotpots bound by PRDM9 “A” and “B” alleles will occur 
at a decreased rate in people of West African ancestry, whereas new diseases will arise due 
to recombination errors near African-enriched hotspots.
METHODS SUMMARY
We assembled SNP array data from 29,589 unrelated people and 222 nuclear families 
genotyped at 490,000–910,000 SNPs from the Candidate Gene Association Resource 
(CARe), studies at the Children’s Hospital of Philadelphia (CHOP), the African American 
Breast Cancer Consortium, the African American Prostate Cancer Consortium and the 
African American Lung Cancer Consortium. To build a recombination map, we used 
HAPMIX to localize candidate crossover positions15, and implemented a Markov Chain 
Monte Carlo (MCMC) that used the probability distributions for the positions of the filtered 
crossovers to infer recombination rates for each of 1.3 million inter-SNP intervals. We also 
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implemented a second MCMC that models each individual’s set of crossovers as a mixture 
of a Shared (S) Map similar to the European deCODE Map and an African-enriched (AE) 
Map, and then assigns each individual an “AE phenotype” corresponding to the proportion 
of their newly detected crossovers assigned to the AE Map. We imputed genotypes at up to 
three million HapMap2 SNPs8 using MaCH26, and then tested each of these SNPs for 
association with the AE phenotype and other recombination-related phenotypes. We 
identified 2,454 candidate African-enriched hotspots with increased recombination rates in 
the YRI vs. CEU maps, and in the AE vs. S maps, and searched for motifs enriched at these 
loci, thus identifying a degenerate 17-bp motif. To study the structure of PRDM9, we 
measured the length of the PRDM9 zinc finger array and genotyped rs6889665 in YRI, CEU 
and the CARe nuclear families; we also carried out imputation based on 1000 Genomes 
Project short read data10 to infer the alleles individuals carry, among 29 previously 
characterized in a sequencing study of PRDM99.
Supplementary Material
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Figure 1. 
Building an African American genetic map. (A) HAPMIX detection of crossovers between 
segments of inferred ancestry is illustrated in a father-mother-child trio. Black segments 
show inferred crossovers; arrows showtransmission of ancestral crossovers from parent to 
child, Purple/green segments show de novo events (paternal/maternal origin respectively), 
corresponding to events identified directly using two additional children (bottom,“Pedigree 
inferred”).(B) The AA Map localizes five hotspots in a region of the MHC whose positions 
(blue) were previously mapped by sperm typing1. (C) Comparison of maps shows a hotspot 
at 33.1Mb in the African-derived AA and YRI maps, but not the deCODE and CEU maps 
(all maps smoothed to 10kb).
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Figure 2. 
Association of PRDM9 genetic variation with hotspot activity. (A) A GWAS measuring 
association of the “African-enrichment” (AE) phenotype shows a single genome-wide 
significant peak at PRDM9, with rs6889665 the best associated SNP. (B) Relationship 
between alleles at the rs6889665 and predicted binding target of the PRDM9 zinc finger 
array9 for West African and European samples. The alleles are grouped into 8 clusters 
according to their best-matching region to the 13-bp motif, and annotated by the number of 
bases matching the motif. The African-enriched rs6889665 “C” allele always co-occurs with 
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motifs with a poor (5/8) match to the 13-mer. (C) Gene tree32 of the LD block containing the 
PRDM9 ZF array (Methods); numbered circles show SNPs and significant P-values for 
association, after conditioning on rs6889665.
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Figure 3. 
A sequence motif specifying the positions of African-enriched hotspots. (A) Logo plot 
showing a degenerate 17-bp hotspot motif, with stack height proportional to -log P-value, 
and relative letter height proportional to the mean crossover rate increase given each base. 
Below is the bioinformatic PRDM9 binding prediction for the rs6889665 AE associated 
alleles (from Figure 2B), matching the motif at 10/11 bases (lines). (B) Average crossover 
rate (in 2 kb sliding windows) in the AA (red line) and deCODE (black line) maps 
surrounding the 500 strongest motif matches. (C) In seven rs6889665 “CC” individuals from 
the pedigree study, we localized 82 crossovers to within 10 kb, and plot average AA, YRI, 
deCODE and CEU map rates. There is no strong peak above local background in the 
deCODE or CEU maps.
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